Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
<p>Differences in intrinsic subtype classification from baseline to surgery in the POETIC subset and the NeoAI study. Changes of intrinsic subtype classifications in all the POETIC-treated samples (<b>A</b>); in POETIC Luminal B–treated samples (<b>B</b>); in POETIC con...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Övriga upphovsmän: | , , , , , , , , , , |
| Publicerad: |
2025
|
| Ämnen: | |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
| _version_ | 1849927634758139904 |
|---|---|
| author | Milana A. Bergamino (15038015) |
| author2 | Gabriele Morani (15038018) Joel Parker (15038021) Eugene F. Schuster (9726535) Mariana F. Leal (15038024) Elena López-Knowles (15038027) Holly Tovey (9360536) Judith M. Bliss (8827107) John F.R. Robertson (15025368) Ian E. Smith (1545553) Mitch Dowsett (645) Maggie C.U. Cheang (14946768) |
| author2_role | author author author author author author author author author author author |
| author_facet | Milana A. Bergamino (15038015) Gabriele Morani (15038018) Joel Parker (15038021) Eugene F. Schuster (9726535) Mariana F. Leal (15038024) Elena López-Knowles (15038027) Holly Tovey (9360536) Judith M. Bliss (8827107) John F.R. Robertson (15025368) Ian E. Smith (1545553) Mitch Dowsett (645) Maggie C.U. Cheang (14946768) |
| author_role | author |
| dc.creator.none.fl_str_mv | Milana A. Bergamino (15038015) Gabriele Morani (15038018) Joel Parker (15038021) Eugene F. Schuster (9726535) Mariana F. Leal (15038024) Elena López-Knowles (15038027) Holly Tovey (9360536) Judith M. Bliss (8827107) John F.R. Robertson (15025368) Ian E. Smith (1545553) Mitch Dowsett (645) Maggie C.U. Cheang (14946768) |
| dc.date.none.fl_str_mv | 2025-11-25T12:05:30Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30705380 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Figure_1_from_Impact_of_Duration_of_Neoadjuvant_Aromatase_Inhibitors_on_Molecular_Expression_Profiles_in_Estrogen_Receptor_positive_Breast_Cancers/30705380 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Biomarkers Genetic biomarkers Breast Cancer Drug Resistance Novel mechanisms Endocrinology Translational Research |
| dc.title.none.fl_str_mv | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Differences in intrinsic subtype classification from baseline to surgery in the POETIC subset and the NeoAI study. Changes of intrinsic subtype classifications in all the POETIC-treated samples (<b>A</b>); in POETIC Luminal B–treated samples (<b>B</b>); in POETIC control samples (<b>C</b>); in POETIC Luminal B control samples (<b>D</b>); in all the NeoAI study samples (<b>E</b>), and in NeoAI Luminal B samples (<b>F</b>). Her2-E, Her2 enriched; LumB, Luminal B; LumA, Luminal A; 2 wk, 2-week time point.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_7fc5861f2a6a2a128344cd8579921009 |
| identifier_str_mv | 10.1158/1078-0432.30705380 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30705380 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast CancersMilana A. Bergamino (15038015)Gabriele Morani (15038018)Joel Parker (15038021)Eugene F. Schuster (9726535)Mariana F. Leal (15038024)Elena López-Knowles (15038027)Holly Tovey (9360536)Judith M. Bliss (8827107)John F.R. Robertson (15025368)Ian E. Smith (1545553)Mitch Dowsett (645)Maggie C.U. Cheang (14946768)CancerTumor BiologyCancer Detection and DiagnosisTherapeutic Research and DevelopmentBiomarkersGenetic biomarkersBreast CancerDrug ResistanceNovel mechanismsEndocrinologyTranslational Research<p>Differences in intrinsic subtype classification from baseline to surgery in the POETIC subset and the NeoAI study. Changes of intrinsic subtype classifications in all the POETIC-treated samples (<b>A</b>); in POETIC Luminal B–treated samples (<b>B</b>); in POETIC control samples (<b>C</b>); in POETIC Luminal B control samples (<b>D</b>); in all the NeoAI study samples (<b>E</b>), and in NeoAI Luminal B samples (<b>F</b>). Her2-E, Her2 enriched; LumB, Luminal B; LumA, Luminal A; 2 wk, 2-week time point.</p>2025-11-25T12:05:30ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30705380https://figshare.com/articles/figure/Figure_1_from_Impact_of_Duration_of_Neoadjuvant_Aromatase_Inhibitors_on_Molecular_Expression_Profiles_in_Estrogen_Receptor_positive_Breast_Cancers/30705380CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307053802025-11-25T12:05:30Z |
| spellingShingle | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Milana A. Bergamino (15038015) Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Biomarkers Genetic biomarkers Breast Cancer Drug Resistance Novel mechanisms Endocrinology Translational Research |
| status_str | publishedVersion |
| title | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| title_full | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| title_fullStr | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| title_full_unstemmed | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| title_short | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| title_sort | Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers |
| topic | Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Biomarkers Genetic biomarkers Breast Cancer Drug Resistance Novel mechanisms Endocrinology Translational Research |